Cancer Therapy Advisor news story
In people living with HIV (PWH) and advanced solid tumors who are receiving antiretroviral therapy, treatment with nivolumab plus cabozantinib has a manageable safety profile, according to research published in The Oncologist.
The findings support further, larger studies in PWH, especially in those with Kaposi sarcoma, study researchers suggested.
Read the full news story here.
Source : Cancer Therapy Advisor
Related HIV and Co-Infections News
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.